AAAAAA
Results:
1-8
|
Results: 8
Authors:
Passadakis, P
Oreopoulos, D
Citation: P. Passadakis et D. Oreopoulos, Peritoneal dialysis in diabetic patients, ADV RENAL R, 8(1), 2001, pp. 22-41
Authors:
Prakash, S
Walele, A
Dimkovic, N
Bargman, J
Vas, S
Oreopoulos, D
Citation: S. Prakash et al., Experience with a large dose (500 mg) of intravenous iron dextran and ironsaccharate in peritoneal dialysis patients, PERIT DIA I, 21(3), 2001, pp. 290-295
Authors:
Breborowicz, A
Polubinska, A
Pawlaczyk, K
Kuzlan-Pawlaczyk, M
Moberly, J
Martis, L
Oreopoulos, D
Citation: A. Breborowicz et al., Intraperitoneal hyaluronan administration in conscious rats: Absorption, metabolism, and effects on peritoneal fluid dynamics, PERIT DIA I, 21(2), 2001, pp. 130-135
Authors:
Cherney, DZ
Zevallos, G
Oreopoulos, D
Halperin, ML
Citation: Dz. Cherney et al., A physiological analysis of hyponatremia: Implications for patients on peritoneal dialysis, PERIT DIA I, 21(1), 2001, pp. 7-13
Authors:
Passadakis, P
Thodis, E
Vargemezis, V
Oreopoulos, D
Citation: P. Passadakis et al., Long-term survival with peritoneal dialysis in ESRD due to diabetes, CLIN NEPHR, 56(4), 2001, pp. 257-270
Authors:
Breborowicz, A
Polubinska, A
Moberly, J
Ogle, K
Martis, L
Oreopoulos, D
Citation: A. Breborowicz et al., Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats, AM J KIDNEY, 37(3), 2001, pp. 594-600
Authors:
Passadakis, P
Thodis, E
Vargemezis, V
Oreopoulos, D
Citation: P. Passadakis et al., Abysmal prognosis with type 2 diabetes entering dialysis, NEPH DIAL T, 15(8), 2000, pp. 1257-1258
Authors:
Mujais, S
Nolph, K
Gokal, R
Blake, P
Burkart, J
Coles, G
Kawaguchi, Y
Kawanishi, H
Korbet, S
Krediet, R
Lindholm, B
Oreopoulos, D
Rippe, B
Selgas, R
Citation: S. Mujais et al., Evaluation and management of ultrafiltration problems in peritoneal dialysis, PERIT DIA I, 20, 2000, pp. S5-S21
Risultati:
1-8
|